Products3
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Octreotide Acetate
Product Details
NDC Product Code
67457-245Application Number
ANDA079198Marketing Category
ANDA (C73584)Route of Administration
SUBCUTANEOUS, INTRAVENOUSEffective Date
November 9, 2022WATERInactive
Code: 059QF0KO0RClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
OctreotideActive
Code: 75R0U2568IClass: ACTIMQuantity: 100 ug in 1 mL
LACTIC ACID, L-Inactive
Code: F9S9FFU82NClass: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACT
Octreotide Acetate
Product Details
NDC Product Code
67457-239Application Number
ANDA079198Marketing Category
ANDA (C73584)Route of Administration
SUBCUTANEOUS, INTRAVENOUSEffective Date
November 9, 2022LACTIC ACID, L-Inactive
Code: F9S9FFU82NClass: IACT
OctreotideActive
Code: 75R0U2568IClass: ACTIMQuantity: 50 ug in 1 mL
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACT
Octreotide Acetate
Product Details
NDC Product Code
67457-246Application Number
ANDA079198Marketing Category
ANDA (C73584)Route of Administration
SUBCUTANEOUS, INTRAVENOUSEffective Date
November 9, 2022SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACT
OctreotideActive
Code: 75R0U2568IClass: ACTIMQuantity: 500 ug in 1 mL
LACTIC ACID, L-Inactive
Code: F9S9FFU82NClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT